天麻钩藤颗粒治疗隐匿性高血压:随机安慰剂对照试验
该随机安慰剂对照试验纳入251例诊室血压<140/90 mmHg且日间动态血压135-150/85-95 mmHg的隐匿性高血压患者,比较天麻钩藤颗粒与安慰剂治疗4周的疗效。结果显示天麻钩藤颗粒组日间和24小时动态血压下降幅度显著大于安慰剂组,仅报告1例不良事件。
要点
- 天麻钩藤颗粒可显著降低隐匿性高血压患者的日间和24小时动态血压。
- 诊室血压和夜间血压未见显著组间差异。
- 仅1例不良事件(日间嗜睡),无严重不良事件。
核心结论
- 天麻钩藤颗粒降压治疗对隐匿性高血压患者有效。
研究设计与样本
- 随机、安慰剂对照试验,纳入251例诊室血压<140/90 mmHg且日间动态血压135-150/85-95 mmHg的隐匿性高血压患者,按1:1随机分配至天麻钩藤颗粒或安慰剂组,每次5-10 g,每日两次,治疗4周。
主要发现
- 意向性分析中,天麻钩藤颗粒组日间收缩压/舒张压降低5.44/3.39 mmHg,安慰剂组降低2.91/1.60 mmHg。
- 日间血压降幅组间差异为2.52/1.79 mmHg(P≤0.025),24小时血压降幅组间差异为2.33/1.49 mmHg(P≤0.012)。
- 诊室血压和夜间血压的组间差异不显著(P≥0.162)。
- 符合方案分析(229例)结果相似。
- 仅报告1例不良事件(日间嗜睡),无严重不良事件。
临床怎么用
- 对于诊室血压正常但日间动态血压升高的隐匿性高血压患者,可考虑使用天麻钩藤颗粒以降低日间和24小时动态血压。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Masked hypertension is associated with adverse cardiovascular outcomes. Nonetheless, no randomized controlled trials exist in the treatment of masked hypertension. The aim of this randomized, placebo-controlled trial was to investigate the efficacy and safety of blood pressure (BP)-lowering treatment with a Chinese herbal formula, gastrodia-uncaria granules, in patients with masked hypertension. METHODS: Patients with an office BP of <140/90 mm Hg and daytime ambulatory BP of 135 to 150 mm Hg systolic or 85 to 95 mm Hg diastolic were randomly assigned 1:1 to the treatment of gastrodia-uncaria granules or placebo 5 to 10 g twice daily for 4 weeks. The primary efficacy variable was the change in daytime ambulatory BP. RESULTS: At baseline, office and daytime BP of the 251 participants (mean age, 50.4 years; 53.4% men; mean body mass index 24.5 kg/m2; and 2.8%, 1.6%, and 30.7% with cardiovascular disease, diabetes, and smoking, respectively) averaged 129/82 and 135/89 mm Hg, respectively. In the intention-to-treat analysis, daytime systolic/diastolic BP was reduced by 5.44/3.39 and 2.91/1.60 mm Hg in the gastrodia-uncaria granules and placebo groups, respectively. The between-group difference in BP reductions was significant for the daytime (2.52/1.79 mm Hg; P≤0.025) and 24-hour BP (2.33/1.49 mm Hg; P≤0.012), but not for the clinic and nighttime BPs (P≥0.162). The per-protocol analysis in 229 patients produced similar results. Only 1 adverse event (sleepiness during the day) was reported, and no serious adverse event occurred. CONCLUSIONS: BP-lowering treatment with Chinese traditional medicine gastrodia-uncaria granules is efficacious for patients with masked hypertension. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02156024.
引用
- Zhang DY, Cheng YB, Guo QH, et al. Treatment of Masked Hypertension with a Chinese Herbal Formula: A Randomized, Placebo-Controlled Trial. Circulation. 2020. PMID: 33019798. doi:10.1161/CIRCULATIONAHA.120.046685
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。